Target intelligence / Profile preview

Phosphoglycerate mutase 2 (PGAM2)

Target
PGAM2
Molecular classification
Enzyme
01

Overview

Phosphoglycerate mutase 2 (PGAM2) is a muscle-specific glycolytic enzyme responsible for catalyzing the reversible conversion of 3-phosphoglycerate to 2-phosphoglycerate, a key step in glycolysis[1][2][3][4]. It functions as a homodimer in skeletal muscle, though heterodimers with the brain isoform (PGAM1) are also possible. Mutations in PGAM2 cause muscle phosphoglycerate mutase deficiency, also called Glycogen storage disease X (GSD10), which manifests as muscle cramps and breakdown due to impaired energy production in muscle. Recent research also shows that PGAM2 can translocate to the nucleus (nucleolus) where it may help stabilize nucleolar structure, participate in mRNA transcriptional regulation, and assist in ribosomal assembly, with import regulated by insulin/IGF1-PI3K-AKT-mTOR signaling and interaction with 14-3-3 proteins[2].

Other names
BPG-dependent PGAM 2Muscle-specific phosphoglycerate mutasePhosphoglycerate mutase isozyme MGSD10PGAM-MPGAMMphosphoglycerate mutase 2 (muscle)
02

Mechanism of action

Enzyme inhibition or genetic loss results in reduced glycolytic flux and impaired energy supply to muscle tissue[1][4].

03

Biological functions

Glycolysis (conversion of 3-phosphoglycerate to 2-phosphoglycerate)Energy metabolismNuclear structural stabilization (nucleolar maintenance)Regulation of mRNA expressionRibosome biogenesis (pre-ribosomal subunit assembly)
04

Disease associations

Glycogen storage disease type X (muscle phosphoglycerate mutase deficiency)Muscle cramping, exercise-induced myopathyOther (role in bioenergetics of proliferative diseases is likely, but not directly documented in provided sources)
05

Safety considerations

Targeting may impair skeletal muscle energy homeostasis.Deficiency causes muscle cramping, exercise intolerance, muscle breakdown[1].
06

Biomarkers

Deficiency/mutation can be used to diagnose Glycogen storage disease type X[1][3][4].

Beyond the preview

Go deeper on Phosphoglycerate mutase 2 (PGAM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoglycerate mutase 2 (PGAM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call